| Announce Date | 12/22/2025 |
| EPS Normalized Actual | $-0.73 (Miss by $-0.18) |
| EPS GAAP Actual | $-0.73 (Miss by $-0.18) |
| Revenue Actual | $0B |
| Revenue Surprise | Beat by $0M |
| Announce Date | 01/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.57958 |
| EPS GAAP Estimate | $-0.57958 |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Oct 2030 | 1.3475 | 7.1 | 0.1131 | 4.04576 | 2 |
| Oct 2029 | -0.03 | -319 | -0.03 | -0.03 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | -0.74 | -0.155 | 0B | NAN% | 0M |
| FQ3 2025 (Jul 2025) | -0.57 | 0 | 0B | NAN% | 0M |
| FQ2 2025 (Apr 2025) | 0.51 | 0.96 | 0B | NAN% | 0M |
| FQ1 2025 (Jan 2025) | 0.0483 | 0.0483 | 0B | NAN% | 0M |
| FQ4 2024 (Oct 2024) | 0 | 0 | 0B | NAN% | 0M |
| FQ3 2024 (Jul 2024) | 0.0003 | 0.0003 | 0B | NAN% | 0M |
| FQ2 2024 (Apr 2024) | -0.38 | -0.38 | 0B | NAN% | 0M |
| FQ4 2022 (Oct 2022) | 0 | 0 | 0B | NAN% | 0M |
FQ4 Announce Date
01/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.57958
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Oct 2027) | -0.36 | -- | -0.36 | -0.36 | 5 |
| FQ3 2027 (Jul 2027) | -0.43 | -- | -0.43 | -0.43 | 3 |
| FQ2 2027 (Apr 2027) | -0.47 | -- | -0.47 | -0.47 | 3 |
| FQ1 2027 (Jan 2027) | -0.63 | -- | -0.63 | -0.63 | 5 |
| FQ4 2026 (Oct 2026) | -0.62251 | -18.87 | -0.62251 | -0.62251 | 1 |
| FQ3 2026 (Jul 2026) | -0.62378 | 8.62 | -0.62378 | -0.62378 | 1 |
| FQ2 2026 (Apr 2026) | -0.57942 | 188.02 | -0.57942 | -0.57942 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Oct 2027) | 0.01B | -- | 0.01B | 0.01B | 1 |
| FQ3 2027 (Jul 2027) | 0.01B | -- | 0.01B | 0.01B | 1 |
| FQ2 2027 (Apr 2027) | 0B | -- | 0B | 0B | 0 |
| FQ1 2027 (Jan 2027) | 0B | -- | 0B | 0B | 0 |
| FQ4 2026 (Oct 2026) | 0B | -- | 0B | 0B | 0 |
| FQ3 2026 (Jul 2026) | 0B | -- | 0B | 0B | 0 |
| FQ2 2026 (Apr 2026) | 0B | -- | 0B | 0B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
2
EPS # of in-lines
3
Revenue # of Beats
0
Revenue # of Misses
0
Revenue # of in-lines
8
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | -0.585 | -0.74 | -0.155 | 20.95% |
| FQ3 2025 (Jul 2025) | -0.57 | -0.57 | 0 | 0% |
| FQ2 2025 (Apr 2025) | -0.45 | 0.51 | 0.96 | 188.24% |
| FQ1 2025 (Jan 2025) | 0.0483 | 0.0483 | 100% | |
| FQ4 2024 (Oct 2024) | 0 | 0 | NAN% | |
| FQ3 2024 (Jul 2024) | 0.0003 | 0.0003 | 100% | |
| FQ2 2024 (Apr 2024) | -0.38 | -0.38 | 100% | |
| FQ4 2022 (Oct 2022) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | $0B | $0B | $0M | NAN% |
| FQ3 2025 (Jul 2025) | $0B | $0B | $0M | NAN% |
| FQ2 2025 (Apr 2025) | $0B | $0B | $0M | NAN% |
| FQ1 2025 (Jan 2025) | $0B | $0B | $0M | NAN% |
| FQ4 2024 (Oct 2024) | $0B | $0B | $0M | NAN% |
| FQ3 2024 (Jul 2024) | $0B | $0B | $0M | NAN% |
| FQ2 2024 (Apr 2024) | $0B | $0B | $0M | NAN% |
| FQ4 2022 (Oct 2022) | $0B | $0B | $0M | NAN% |